Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Eklund, Elizabeth A.
Professor
Bio
The focus of my laboratory is to understand the key events in normal myelopoiesis and how leukemia-associated mutations derange these processes during leukemogenesis.